Skip to main content
Search RSC
Clinical Research Sites
Summary of Resources
Safety
Protocol Registration
Personnel Information
Protocol Information in DAIDS-ES
DAIDS Record Storage Assessment
DAIDS Financial Disclosure Forms
Informed Consent Process Information
Network & Protocol Teams
DAIDS Drug Risk Lists
Developing Protocols
Protocol Templates
Submit a Protocol
ClinicalTrials.gov
DAIDS Protocol Risk Worksheet
Trial Master File
Clinical Trials Insurance
Useful Links
DAIDS Staff
Resources
About Us
About DAIDS & RSC
News & Updates
FAQs
Events
Contact Us
Breadcrumb
Home
Clinical Research Sites
HIV-1 Adenovirus Type 4-Vectored (A549 cells) Vaccines (Ad4-Env150KN and Ad4-Env145NFL)
Document Date
Thursday, February 8, 2024
